Cytokines and serotonin transporter in patients with major depression

Chiung Wen Tsao, Yee Shin Lin, Chwen Cheng Chen, Chyi Huey Bai, Shin Rung Wu

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Altered cytokine secretion as a mechanism in the etiology of depression is still obscure. The serotonin transporter (5-HTT) may play an important role in the termination of serotonergic neurotransmission by serotonin (5-HT) uptaking into presynaptic neurons and representing as an initial action site for selective 5-HTT reuptake inhibitors (SSRI). In our study, we evaluated whether cytokines and 5-HTT acted as biological markers for depression. Blood samples were collected from 42 participants. The differences in cytokine and 5-HTT mRNA expressions of leukocytes were assessed between the patients with major depression (n = 20) and the healthy controls (n = 22), along with the measurements prior and after treatment with a SSRI, fluoxetine, for 3 months in the follow-up patient group (n = 8). The results revealed that the mRNA expressions of IL-1β, IL-6, IFNγ, TNFα, and 5-HTT were higher in the depressed patients than those of the healthy controls. The higher level of mRNA expressions of IFNγ and 5-HTT diminished after fluoxetine treatment. Furthermore, we found a positive correlation between 5-HTT and cytokines mRNA expressions in total participants, which suggested that pro-inflammatory cytokines and 5-HTT might play critical roles in the pathogenesis of major depression and that their levels were affected by chronic treatment with 5-HTT inhibitors.

Original languageEnglish
Pages (from-to)899-905
Number of pages7
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume30
Issue number5
DOIs
Publication statusPublished - Jul 2006
Externally publishedYes

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Cytokines
Messenger RNA
Fluoxetine
Serotonin
Interleukin-1
Synaptic Transmission
Interleukin-6
Leukocytes
Therapeutics
Biomarkers
Neurons

Keywords

  • Cytokines
  • Major depression
  • Serotonin transporter

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Cytokines and serotonin transporter in patients with major depression. / Tsao, Chiung Wen; Lin, Yee Shin; Chen, Chwen Cheng; Bai, Chyi Huey; Wu, Shin Rung.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 30, No. 5, 07.2006, p. 899-905.

Research output: Contribution to journalArticle

Tsao, Chiung Wen ; Lin, Yee Shin ; Chen, Chwen Cheng ; Bai, Chyi Huey ; Wu, Shin Rung. / Cytokines and serotonin transporter in patients with major depression. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006 ; Vol. 30, No. 5. pp. 899-905.
@article{3e89c46ca5414c71b6de6c937082ea4e,
title = "Cytokines and serotonin transporter in patients with major depression",
abstract = "Altered cytokine secretion as a mechanism in the etiology of depression is still obscure. The serotonin transporter (5-HTT) may play an important role in the termination of serotonergic neurotransmission by serotonin (5-HT) uptaking into presynaptic neurons and representing as an initial action site for selective 5-HTT reuptake inhibitors (SSRI). In our study, we evaluated whether cytokines and 5-HTT acted as biological markers for depression. Blood samples were collected from 42 participants. The differences in cytokine and 5-HTT mRNA expressions of leukocytes were assessed between the patients with major depression (n = 20) and the healthy controls (n = 22), along with the measurements prior and after treatment with a SSRI, fluoxetine, for 3 months in the follow-up patient group (n = 8). The results revealed that the mRNA expressions of IL-1β, IL-6, IFNγ, TNFα, and 5-HTT were higher in the depressed patients than those of the healthy controls. The higher level of mRNA expressions of IFNγ and 5-HTT diminished after fluoxetine treatment. Furthermore, we found a positive correlation between 5-HTT and cytokines mRNA expressions in total participants, which suggested that pro-inflammatory cytokines and 5-HTT might play critical roles in the pathogenesis of major depression and that their levels were affected by chronic treatment with 5-HTT inhibitors.",
keywords = "Cytokines, Major depression, Serotonin transporter",
author = "Tsao, {Chiung Wen} and Lin, {Yee Shin} and Chen, {Chwen Cheng} and Bai, {Chyi Huey} and Wu, {Shin Rung}",
year = "2006",
month = "7",
doi = "10.1016/j.pnpbp.2006.01.029",
language = "English",
volume = "30",
pages = "899--905",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Cytokines and serotonin transporter in patients with major depression

AU - Tsao, Chiung Wen

AU - Lin, Yee Shin

AU - Chen, Chwen Cheng

AU - Bai, Chyi Huey

AU - Wu, Shin Rung

PY - 2006/7

Y1 - 2006/7

N2 - Altered cytokine secretion as a mechanism in the etiology of depression is still obscure. The serotonin transporter (5-HTT) may play an important role in the termination of serotonergic neurotransmission by serotonin (5-HT) uptaking into presynaptic neurons and representing as an initial action site for selective 5-HTT reuptake inhibitors (SSRI). In our study, we evaluated whether cytokines and 5-HTT acted as biological markers for depression. Blood samples were collected from 42 participants. The differences in cytokine and 5-HTT mRNA expressions of leukocytes were assessed between the patients with major depression (n = 20) and the healthy controls (n = 22), along with the measurements prior and after treatment with a SSRI, fluoxetine, for 3 months in the follow-up patient group (n = 8). The results revealed that the mRNA expressions of IL-1β, IL-6, IFNγ, TNFα, and 5-HTT were higher in the depressed patients than those of the healthy controls. The higher level of mRNA expressions of IFNγ and 5-HTT diminished after fluoxetine treatment. Furthermore, we found a positive correlation between 5-HTT and cytokines mRNA expressions in total participants, which suggested that pro-inflammatory cytokines and 5-HTT might play critical roles in the pathogenesis of major depression and that their levels were affected by chronic treatment with 5-HTT inhibitors.

AB - Altered cytokine secretion as a mechanism in the etiology of depression is still obscure. The serotonin transporter (5-HTT) may play an important role in the termination of serotonergic neurotransmission by serotonin (5-HT) uptaking into presynaptic neurons and representing as an initial action site for selective 5-HTT reuptake inhibitors (SSRI). In our study, we evaluated whether cytokines and 5-HTT acted as biological markers for depression. Blood samples were collected from 42 participants. The differences in cytokine and 5-HTT mRNA expressions of leukocytes were assessed between the patients with major depression (n = 20) and the healthy controls (n = 22), along with the measurements prior and after treatment with a SSRI, fluoxetine, for 3 months in the follow-up patient group (n = 8). The results revealed that the mRNA expressions of IL-1β, IL-6, IFNγ, TNFα, and 5-HTT were higher in the depressed patients than those of the healthy controls. The higher level of mRNA expressions of IFNγ and 5-HTT diminished after fluoxetine treatment. Furthermore, we found a positive correlation between 5-HTT and cytokines mRNA expressions in total participants, which suggested that pro-inflammatory cytokines and 5-HTT might play critical roles in the pathogenesis of major depression and that their levels were affected by chronic treatment with 5-HTT inhibitors.

KW - Cytokines

KW - Major depression

KW - Serotonin transporter

UR - http://www.scopus.com/inward/record.url?scp=33646904326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646904326&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2006.01.029

DO - 10.1016/j.pnpbp.2006.01.029

M3 - Article

C2 - 16616982

AN - SCOPUS:33646904326

VL - 30

SP - 899

EP - 905

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 5

ER -